TP53 and myelodysplastic syndrome: For instance, in native CH, the presence of mutations in spliceosome genes, IDH1/2, TP53, or multiple mutations, and high-variant allele frequency (VAF) are associated with an increased risk of subsequent acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).